|
TSNAX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.20060000000788E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32969999999222E-05 |
| Normal-vs-Stage2 |
1.634060E-02 |
| Normal-vs-Stage3 |
8.413100E-04 |
| Normal-vs-Stage4 |
1.604210E-03 |
| Stage1-vs-Stage2 |
2.754200E-01 |
| Stage1-vs-Stage3 |
6.114800E-01 |
| Stage1-vs-Stage4 |
7.321400E-01 |
| Stage2-vs-Stage3 |
5.362600E-01 |
| Stage2-vs-Stage4 |
3.075800E-01 |
| Stage3-vs-Stage4 |
5.186200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.84430000000191E-05 |
| Normal-vs-AfricanAmerican |
8.508000E-01 |
| Normal-vs-Asian |
1.93224999999186E-05 |
| Caucasian-vs-AfricanAmerican |
9.735300E-03 |
| Caucasian-vs-Asian |
2.694000E-01 |
| AfricanAmerican-vs-Asian |
3.659500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.43030000000233E-05 |
| Normal-vs-Female |
2.424300E-04 |
| Male-vs-Female |
2.693600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8174199999943E-05 |
| Normal-vs-Age(41-60Yrs) |
6.28429999999236E-05 |
| Normal-vs-Age(61-80Yrs) |
1.587890E-02 |
| Normal-vs-Age(81-100Yrs) |
4.244000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.309200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.218200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.219600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.670400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.749600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.922000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.137600E-01 |
| Classical-VS-Follicular |
9.708000E-01 |
| Classical-VS-Other |
6.141900E-02 |
| Classical-VS-Normal |
7.164400E-04 |
| Tall-VS-Follicular |
2.073400E-01 |
| Tall-VS-Other |
1.465650E-01 |
| Tall-VS-Normal |
1.791380E-04 |
| Follicular-VS-Other |
8.547700E-02 |
| Follicular-VS-Normal |
3.936400E-03 |
| Other-VS-Normal |
5.629400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.362640E-04 |
| Normal-vs-N1 |
1.74263999999091E-05 |
| N0-vs-N1 |
1.524240E-01 |
|
|
